A2Z Cust2Mate Solutions vs ChronoScale
AZ and CHRN side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AZ | CHRN |
|---|---|---|
| Size and price | ||
| Share price | $6.25 | $11.52 |
| Change, 1 year | 12.6% | 130% |
| Change, 5 years | −68.4% | −77.5% |
| Beta (5Y) | 1.10 | 1.29 |
| Employees | 122 | – |
| StockData Score | ||
| Total score | 4 | – |
| Valuation score | 0 | – |
| Growth score | 1 | – |
| Performance score | 1 | – |
| Health score | 2 | – |
| Dividend score | 0 | – |
| Growth | ||
| Revenue growth (TTM) | 153% | – |
| Revenue growth, 5Y average | 49.2% | – |
| Profitability | ||
| Gross margin | 20.1% | – |
| Operating margin | −268% | – |
| Net margin | −236% | – |
| FCF margin | −248% | – |
| Return on equity | −69.8% | – |
| Return on invested capital | −108% | – |
| Financial health | ||
| Debt / equity | 0.03 | – |
| Current ratio | 7.52 | – |
| Piotroski F-score | 4 | – |
| Ownership | ||
| Held by institutions | 44.4% | 0.73% |
| Held by insiders | 2.5% | 100% |
| Insider net buying, 12 months | – | $1.2M |
| Short interest, % of float | 12.1% | – |
Go deeper
- AZ stock overview
- AZ income statement
- AZ valuation and score
- CHRN stock overview
- CHRN income statement
- CHRN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.